Omnitram Pharmacokinetic and Analgesic Study Following CY2D6 Inhibition With Paroxetine In Healthy Volunteers
Clinical trial NCT03312777 · COMPLETED
Trial details
- NCT number
- NCT03312777
- Sponsor
- Syntrix Biosystems, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-31
- Primary completion
- 2017-12-15
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.